Enterprise Value (EV)
Paying user area
Try for free
Bristol-Myers Squibb Co. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Debt to Equity since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Bristol-Myers Squibb Co. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Bristol-Myers Squibb Co., current enterprise value calculation
| Current share price (P) | |
| No. shares of common stock outstanding | |
| US$ in millions | |
| Common equity (market value)1 | |
| Add: Preferred stock, $2 convertible series, par value $1 per share (per books) | |
| Add: Noncontrolling interest (per books) | |
| Total equity | |
| Add: Short-term debt obligations (per books) | |
| Add: Long-term debt, excluding current portion (per books) | |
| Total equity and debt | |
| Less: Cash and cash equivalents | |
| Less: Marketable debt securities | |
| Enterprise value (EV) | |
Based on: 10-K (reporting date: 2024-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Bristol-Myers Squibb Co., EV calculation
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Bristol-Myers Squibb Co. Annual Report.
3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
- Common Equity (Market Value)
- The common equity exhibited a general upward trend from 2020 through 2022, increasing from approximately $134.4 billion to $151.6 billion. However, a significant decline occurred in 2023, with a decrease to around $98.5 billion, followed by a recovery in 2024 to approximately $114 billion. This pattern suggests a period of volatility or external influence affecting market valuation in 2023, with partial stabilization thereafter.
- Total Equity
- Total equity mirrored the trend of common equity closely, escalating from about $134.5 billion in 2020 to $151.7 billion in 2022, then sharply declining to $98.6 billion in 2023 before rebounding to nearly $114 billion in 2024. The parallel movement indicates that the components of total equity other than common equity remained relatively consistent during these periods.
- Total Equity and Debt
- Total equity and debt rose modestly from approximately $185.2 billion in 2020 to $191 billion in 2022, signaling steady leverage and capital structure. Subsequently, a marked contraction to $138.3 billion occurred in 2023, corresponding with the decline seen in equity figures. The figure then increased to $163.6 billion in 2024, indicating a partial restoration of financial resources or capital commitment.
- Enterprise Value (EV)
- Enterprise value experienced a gradual increase from $169.3 billion in 2020 to $181.8 billion in 2022, reflecting growing market valuation and debt levels. In 2023, a sharp decrease to $126 billion was observed, aligning with declines in equity and total capitalization, followed by an increase to $152.8 billion in 2024. The EV trend underscores a notable disruption in 2023, impacting both market perceptions and the company's valuation base, with a trend toward recovery the following year.